Introduction
Upper extremity digital ischemia (UEDI) is a persistent peripheral vascular disease.
Diagnosis remains a real challenge to identify and consequently evaluation of etiologies and determination of therapeutic strategies has proved difficult. The incidence of UEDI is about 2 cases per 100,000 persons per year (1,2) with symptomatic ischemia of the upper extremity being encountered less frequently than lower extremity vascular insufficiency.
The main causes generally identified in literature are cardiac or arterial embolism, local thrombosis, systemic autoimmune connective tissue diseases (especially systemic sclerosis), vasculitis or traumatic injury (3) .
Past literature shows that only a few studies have focused on the prevalence of etiologies, in patients diagnosed with digital ischemia, with long-term clinical outcomes thus being rarely discussed. Only two retrospective studies about UEDI, with a cohort of over one hundred patients, were reported (2, 4, 5) .
Moreover, there are only few studies published about long-term follow up of UEDI. Three of them were among specific patients : cancer-induced UEDI (4), hypothenar hammer syndrome (6), systemic sclerosis (7)). Only two studies were about general follow up of UEDI, both with a limited number of cases (8, 9) .
The purpose of this retrospective study was to evaluate etiologies in a large cohort and to assess long-term clinical outcomes of patients diagnosed with digital ischemia.
[Texte]
Material and Methods
In this retrospective cohort study, we included patients hospitalized for UEDI and outpatients visiting for UEDI in a university hospital between January 1, 2000 and December 31, 2016. We identified patients, based on IDC-10 (I742, T345 and I744 codes) through the medical data processing department. This study was approved by the Local Ethics Review committee. UEDI inclusion criterion was the first episode of UEDI diagnosed, defined by: painful and digital blanching, cyanosis, ulceration of the fingers, gangrene or change of cutaneous temperature, due to vascular pathology. We include all UEDI cases, not only those limited to fingers.
Clinical assessment included demographic data (age, gender, occupation), medical history, cardiovascular risk factors (CVRF), substance abuse, number of recurrence, long-term clinical outcomes and cardiovascular events (stroke, myocardial ischemia, lower limbs ischemia).
Each etiology was determined as follow: Systemic Sclerosis cases (SSc) were diagnosed through ACR/EULAR 2013's criteria (10); thromboangiitis obliterans cases (TAO) by Mills 2003's criteria (11); cardio-embolic (CE) diseases were diagnosed through ultrasound criteria and Holter monitoring; vasculitis cases were diagnosed by histology or by cryoglobulinemia positivity or ANCA positivity and further with giant cell arteritis and Takayasu's Arteritis by ACR or Ishikawa's criteria; thrombophilias were determined through specific tests; cancer were diagnosed by histology and molecular biology; iatrogenic etiology was defined by intrinsic and extrinsic probability for drug-induced iatrogenic ischemia and by corresponding temporality, for technical-induced iatrogenic ischemia ( such as artery cannulation) and finally hypothenar hammer syndrome was identified with the help of occupational health service. When criteria were not found, diagnosis was made following intrinsic and extrinsic causalities. Idiopathic ischemia was defined as such after negative clinical, laboratory and imaging examination. When several etiologies could be incriminated, we chose to include the UEDI case in the etiology most susceptible to be responsible for.
Long-term follow-up was performed by chronological analysis of medical records and by regimenting telephone interviews with patient's general practitioners.
Statistical analysis
Results were expressed as mean ± standard deviation (SD) or as median, range. Categorical variable for the groups were compared using chi-square tests or Fisher's exact tests when any of the expected cell counts of a 2x2 table was less than 5. Comparisons of quantitative variables were performed using Student's t-test. ANOVA test was performed with a Bonferroni correction after test to individualize group differences. A p-value < 0.05 was considered statistically significant. Survival [Texte] curves were developed to compare cardio-embolic, SSc, idiopathic and TAO groups. Only new events were considered. Survival free of digital ischemia, cardiovascular event (stroke, acute myocardial infarction or acute lower limb arteritis), fingers amputation and global survey were compared. Kaplan-Meier curves were then produced and a log-rank test was performed to analyze the event-free survival. All calculations were done using Graph Pad Prism 6.
Results
Patients' characteristics 323 patients were analyzed. The etiologies of digital ischemia are presented in Table 1 Etiology of digital ischemia Number of patients (%) At the end of the follow-up (average follow-up time: 29.3 months), UEDI associated with cardio embolic disease (DICE) was the highest-occurring etiology in this cohort with 59 patients (18.3%),
SSc was the second highest occurring at 16% (52 cases). 38 cases (11.7%) remained undetermined and were classified as idiopathic UEDI. TAO and iatrogenic UEDI were the fourth highest occurring, equally placed in 9.3% of UEDI.
Half of iatrogenic patients were divided up as followed: 30% of cases (9 patients Connective Tissue Disease, without systemic sclerosis, accounted for 3.1% of cases of digital ischemia with 5 cases of mixed connective tissue disease and anti-synthetase syndrome, dermatomyositis, systemic lupus erythematosus, Sjögren's syndrome, and unclassifiable CTD diagnosed on hepatic biopsy (1 case each).
Among the 11 cases of atherosclerosis' UEDI, we found 10 cases of atherosclerosis stenosis without subclavian aneurysm and 1 case of aortic arch aneurysm.
UEDI was associated with vasculitis in 6.2% of cases: 3 Giant cells arteritis, 2 Takayasu's arteritis, 2 cryoglobulinemia, 1 necrotizing small vessel vasculitis and 2 unclassifiable vasculitis.
Thrombophilias were represented mostly by antiphospholipid syndrome (6 cases) as well as one case of antithrombin deficiency. Infectious causes were four cases of purpura fulminans and 3 cases of endocarditis.
The 5 cases of vasospasm were 3 cases of narcotic intra-arterial injections (cocaine, heroin) and 2 patients who misused buprenorphine, one with a cold exposure during work-time and one extreme vasospasm on peripheral vascular disease. Peripheral embolisms showed two subclavian artery thrombosis and one aortic arch thrombosis.
Finally, 18 cases were consider as « Other » defined by: 4 cases of calciphylaxis, 1 frost injury, 1 circulatory failure, 1 pre-necrotizing state on severe acrocyanosis, 1 abscess on needle stuck in muscle in a former drug addict, 1 disseminated intravascular coagulation, 2 cases of cold agglutinin disease and 2 cases of severe carpal tunnel syndrome. There were also 3 arteriovenous malformations and 2 congenital stenosis (one brachial artery stenosis, one brachiocephalic trunk stenosis). Traumatic causes were mostly due to violent direct traumas: car accident, stab wounds, attempted suicide, and work accidents.
The main characteristics of the population, as well as characteristics of the four most represented etiologies of UEDI are presented in Mean age was 60.5 year old; (14-102 years old); One third were active smokers (36.2%). Highest occurring CVRF was hypertension with 43.7%, then dyslipidemia (22.6%) and diabetes (9.9%).
DICE patients were significantly older than all others groups (p<0.001) except the neoplasia group.
They presented significantly more hypertension than SSc and TAO groups (p<0.0001). The DICE group comprised also fewer tobacco smokers than in the idiopathic group (p<0.0001). In the SSc group, there were significantly more women than in the TAO group (p=0.0006), idiopathic group (p=0.03) and iatrogenic group (p=0.04). TAO patients were significantly younger than those in the iatrogenic group (p<0.001) and in the neoplasia group (p<0.01). There were also significantly more tobacco smokers than in all other groups (p<0.0001) and more cannabis smokers than in all other groups except idiopathic (DICE (p=0.002), neoplasia (p=0.03), SSC and iatrogenic (p=0.01)). In TAO group, there were significantly more men than in the DICE (p=0.048) and neoplasia (p=0.04) groups and patients were also significantly less hypertensive than in all other groups except SSc group (p=0.42). Successful surgical revascularizations were significantly more often than all other groups (p< 0.0001).
Idiopathic group had also significantly more surgical revascularization than SSc group (p=0.002) and TAO group (p =0.02). The rate of recurrence was various and etiology-dependent (Figure 2A ). Recurrence of UEDI was significantly greater in SSc group (n= 7) than in all other groups (p <0.0001 vs idiopathic and DICE, p=0.0004 vs iatrogenic p=0.003 vs TAO and p=0.007 vs neoplasia). In the TAO group, recurrence was significantly greater (n=7) than in DICE (n=1) (p=0.005). There were only 3 recurrences in idiopathic group.
Recurrences, digital amputations, cardiovascular morbidity and mortality
Frequencies of digital amputations and auto-amputations varied, depending on etiologies ( Figure   2B ). The cumulated rate of digital amputation and auto-amputation was higher in SSc group (n=18) (p=0.02) and TAO (n=7) (p=0.03) than in DICE group (n=2). In terms of survival (free of amputation) features, there were no significant differences between the other groups. There were only 4 amputations and auto-amputations in the idiopathic group.
CV events also varied ( Figure 2C ) : the DICE group had more CV events (n= 17) than idiopathic UEDI (n=8) (p=0.04), SSc (n=7) (p=0.0005) and TAO (n=4) (p=0.03).
Global survival was different depending on etiology ( Figure 2D ). Mortality was more frequent in DICE (n=27) than SSC (n=14) (p<0.0001), idiopathic (n= 10) (p=0.0093) and TAO (n=5) (p=0.0007) groups. However, there was no difference between idiopathic group and: SSc (p=0.12), iatrogenic (p=0.51) and TAO group (p = 0.29).
Discussion
This study on digital ischemia is the largest cohort ever reported with 323 patients encountered in tertiary center recruitment in vascular pathology.
At the end of the follow-up DICE was the highest-occurring etiology in this cohort, the second highest occurring was SSc. Idiopathic UEDI were the third highest occurring, TAO and iatrogenic UEDI were the fourth highest occurring, equally placed.
DICE recurs only in a small number of cases in this study. Conversely, in this study, patients with SSC and TAO presented higher number of recurrence. Similarly, patients with SSC/TAO-associated UEDI presented with higher number of cases requiring amputation than DICE patients. This phenomenon may be due to the chronicity of vascular lesions and the disappearance of microcirculatory reserves, associated with distal involvement. In contrast, DICE occurs in arteries of larger caliber, usually without pre-existing lesions, which underpins the success of surgical management and the low amputation rate. DICE, however, is likely to be a marker of overall cardiovascular risk as patients with DICE have more cardiovascular events and have higher mortality than other UEDI groups.
This study showed proximity between DICE and idiopathic UEDI groups. Indeed, there are no survival differences without recurrence of UEDI and no difference in amputation rates between DICE and idiopathic UEDI groups. However, the DICE group had higher mortality and cardiovascular events whilst idiopathic UEDI tended to showcase more cardiovascular events than other groups of UEDI which might suggest that idiopathic UEDI may well be unidentified DICE although in this study, we did not find a significant difference. The low rate of recidivism is also in favor of this proximity. The etiologies of the digital ischemia are numerous and, according to previous studies, there are differences in the distribution of etiologies (Table 3 ). Our results demonstrate that 18.3% of digital ischemia was caused by cardio-embolic disease, 16% were due to systemic sclerosis and 11.7%, 9.3% and 9.3% of idiopathic, TAO and iatrogenic origins respectively. contributed to a greater recruiting of CE patients. Our findings showed that UEDI of undetermined origin, after well-conducted explorations, is not uncommon and accounts for 11.7% in our study; in the literature, idiopathic digital ischemia accounts for 4-22% of cases.
All
Iatrogenic cause was the fourth highest-occurring etiology, in this study, with a rate of 9.6% vs 0 to 2.8% in literature (2, 4, 9, (12) (13) (14) (15) ; where for 3 of 7 other studies, iatrogenic etiology was not a research focus. The stronger representation, in this study, is linked to a broad recruitment of patients, in critical care units, with more drug-induced iatrogenic UEDI. Additionally, the results of previous studies may be limited by the era in which research was carried out as intra-arterial proceedings have developed significantly, particularly in recent years.
Cancer-associated UEDI was found in 2 to 15% of cases. In this study, as in Le Besnerais et al (4), the most common histological type was adenocarcinoma. Myeloproliferative diseases were also frequent here, accounting for 30% of digital ischemia associated with cancer. The time between UEDI and cancer diagnosis varied, with it taking 2 months in a study with intensive initial investigation (4) and 14.3 months, in this study, after a clinical examination, standard blood test and clinical follow-up.
Limits
In this study, patients were included retrospectively in a large time-lapse of sixteen years and so there was data loss. We presented episodes of UEDI from tertiary center recruitment in vascular pathology, where prevalence of CTD and multiple comorbidities are higher. Because diagnosis of occupational pathologies is carried out upstream of our center, they are under-represented in our study while they represent up to 33% in some UEDI studies.
Conclusion
This study describes the largest cohort of UEDI ever reported. For the first time, this study showed that cardio-embolic diseases are the highest occurring of the UEDI etiologies studied. This study also found that iatrogenic cause of UEDI was frequent and increased with the use of vasopressor drugs and multiplication of endoluminal arterial procedures. The long-term follow-up showed: UEDI associated with SSc had a poor local prognosis and DICE presented poor general prognosis. UEDI with SSc and TAO presented with more recurrence. When idiopathic UEDI shows recurrence, those etiologies have to be researched as a priority. This research is even more important because of the higher risk of clinical course towards amputations in those etiologies.
